AbbVie Dividends
| ABBV Stock | USD 219.02 1.91 0.88% |
Dividend Payout Ratio is likely to climb to 2.92 in 2026, whereas Dividends Paid is likely to drop slightly above 7 B in 2026. AbbVie's past performance could be the main factor of why investors trade AbbVie Inc stock today. Investors should clearly understand every aspect of the AbbVie dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest AbbVie's dividend schedule and payout information. AbbVie Inc dividends can also provide a clue to the current valuation of AbbVie.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 12.7 B | 7 B | |
| Dividend Yield | 0.03 | 0.03 | |
| Dividend Payout Ratio | 2.78 | 2.92 | |
| Dividend Paid And Capex Coverage Ratio | 1.80 | 1.71 |
Investing in dividend-paying stocks, such as AbbVie Inc is one of the few strategies that are good for long-term investment. Ex-dividend dates are significant because investors in AbbVie must own a stock before its ex-dividend date to receive its next dividend.
AbbVie Dividends Paid Over Time
Today, most investors in AbbVie Stock are looking for potential investment opportunities by analyzing not only static indicators but also various AbbVie's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of AbbVie dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
AbbVie Historical Dividend Yield Growth
A solid dividend growth pattern of AbbVie could indicate future dividend growth is likely, which can signal long-term profitability for AbbVie Inc. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is AbbVie Inc dividend as a percentage of AbbVie stock price. AbbVie Inc dividend yield is a measure of AbbVie stock productivity, which can be interpreted as interest rate earned on an AbbVie investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Recent AbbVie Dividends Paid (per share)
Dividends Paid |
| Timeline |
AbbVie Expected Dividend Income Per Share
Dividend payment represents part of AbbVie's profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in AbbVie. AbbVie's board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$4.8 |
One Year
AbbVie Inc expected dividend income per share adjusted for ongoing price standard deviation
AbbVie Past Distributions to stockholders
| 14th of November 2025 | ||
| 15th of August 2025 | ||
| 15th of May 2025 | ||
| 15th of April 2025 | ||
| 14th of February 2025 | ||
| 15th of November 2024 | ||
| 15th of August 2024 | ||
| 15th of May 2024 | ||
| 15th of February 2024 |
What growth prospects exist in Biotechnology sector? Can AbbVie capture new markets? Factors like these will boost the valuation of AbbVie. If investors know AbbVie will grow in the future, the company's valuation will be higher. Valuation analysis balances hard financial data with qualitative growth assessments. While each AbbVie valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
Quarterly Earnings Growth (0.89) | Earnings Share 1.26 | Revenue Per Share | Quarterly Revenue Growth 0.091 | Return On Assets |
AbbVie Inc's market price often diverges from its book value, the accounting figure shown on AbbVie's balance sheet. Smart investors calculate AbbVie's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. Since AbbVie's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that AbbVie's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AbbVie represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.